News for hackers. Stuff that matters.
Re:What happened to US life expectancy? by azernik on Tuesday January 07, 2014 @03:29PM (#7019678)
This bit struck home for me:

    Some have also suggested that unfavorable US
    performance is explained by higher risk of iatrogenic
    disease, drug toxicity, hospital-acquired infection,
    and a cultural preference to “do more,” with a bias
    toward new technology, for which risks are understated
    and benefits are unknown.
I know some people who use both the US and the Israeli health systems to some degree, and one contrast I've heard is that Americans (patients as well as doctors) tend to prefer newer, less well-tested (because newer), and more expensive (because still patent-protected and brand-name) drugs even when the new drugs have the same or worse performance than decades-old alternatives. I'm not sure if the health drawbacks of this approach are significant, but the economic ones are stupendous; the newer brand-name drugs can be ten times more expensive than the old ones.

There are no comments on this comment yet.